The appeal of buying pre-IPO shares is simple: a stake in a company you've followed for years, before it goes public. The mechanics of getting that stake are not simple — and a run of 2026 securities enforcement has made clear how much can go wrong between the pitch and the cap table.
This is not a story about one bad actor. It's about a structure. When you buy private shares through a fund, an SPV, or a "pre-IPO access" product, you are usually several steps removed from the company itself, relying on an operator's word that the shares exist, that the price is fair, and that the transfer will actually be recognized. The recent cases are a catalog of what happens when that trust is misplaced.
This article walks through what the SEC's crackdown actually targeted, the three fraud patterns that keep recurring, why the pre-IPO market is structurally vulnerable to them, why even the underlying companies are now disavowing unauthorized deals, and the specific questions to get answered — in writing — before you commit capital.
Key concept
Enforcement targets specific operators, not the asset class. But the cases share one root cause: the buyer of pre-IPO shares is rarely in a position to verify what they're buying. Phantom shares, hidden markups, and unauthorized transfers all exploit that verification gap. The defense isn't avoiding the market — it's treating access as the start of diligence, not the end of it.
What the SEC's Pre-IPO Crackdown Actually Targeted
On August 10, 2026, the SEC charged and settled with private fund adviser Adit Ventures Management, its CEO, and three affiliated general partners over alleged fraud tied to pre-IPO investments in companies including SpaceX and Klarna, per the Commission's press release. The alleged conduct ran from April 2019 through December 2024.
Two of the allegations are worth understanding in detail, because they map directly onto risks any pre-IPO buyer faces. According to the SEC's complaint, as summarized in Bloomberg's reporting: an investor was told a fund owned 32,000 Klarna shares that it did not, and committed roughly $15 million on that basis; and the firm bought SpaceX shares for $420 each while charging a client fund $498 per share, concealing the $78 markup. The SEC also alleged the adviser misused client assets for its own benefit.
Corey A. Schuster, Chief of the SEC Enforcement Division's Asset Management Unit, framed the core failure this way: "Investment advisers are entrusted with acting in their clients' best interests. Here, the defendants allegedly engaged in repeated fraudulent acts to benefit or enrich themselves," per the Commission's press release. The firm and its principal settled the charges — which remain subject to court approval of the consent order — while the CEO publicly rejected the allegations, per Reuters.
The Adit action isn't isolated. It fits a documented pattern of enforcement in the pre-IPO secondary market: in SEC v. Keyport Venture Advisors (E.D.N.Y., September 2024), regulators alleged a roughly $120 million scheme selling interests in funds supposedly holding pre-IPO shares while misrepresenting fees, registration status, and actual ownership; and the private class action Evangelista v. Late Stage Asset Management (E.D.N.Y., July 2024) alleged hidden markups reaching 150% disguised as "no-fee" investments and sold through unregistered agents, affecting more than 4,000 investors, per the National Law Review. The through-line across all of them is not exotic. It's the same handful of mechanics, repeated.
The Three Fraud Patterns That Keep Recurring
Across these cases, three patterns do most of the damage. Recognizing them is the first line of defense.
1. Phantom shares. The fund or SPV claims to hold shares it has not actually secured. In the Adit matter, the SEC alleged an investor committed about $15 million believing a fund held 32,000 Klarna shares it did not. This is the same failure at the center of the SEC's 2012 case against Felix Investments, where funds sold interests in pre-IPO Facebook shares the funds had not secured — the company had blocked the transfer. The structure lets an operator collect capital against ownership that exists only on paper.
2. Hidden markups. The operator buys shares at one price and resells them to you at a higher one, without disclosing the spread. The alleged $420-to-$498 SpaceX markup is a clean example: the buyer sees only the price they're charged, not the operator's cost basis. The spread is a fee — it just doesn't appear as one on any invoice. When it's stacked across multiple intermediaries, the gap between what the shares cost and what you pay can widen dramatically.
3. Unauthorized transfers. The structure claims to convey exposure the company will never recognize, because the transfer was never approved. Private company shares carry transfer restrictions — most notably a right of first refusal (ROFR) and board-approval requirements. A deal that ignores them can leave a buyer holding a claim the company treats as void. As the next section shows, the companies themselves are now saying so out loud.
⚠️ All three patterns share one enabler: distance from the cap table. The further you are from the company, the harder it is to independently confirm the shares exist, what they cost, and whether the transfer is valid. Diligence is how you close that distance.
Why the Pre-IPO Market Is Structurally Vulnerable
Fraud clusters where verification is hard and urgency is high. The pre-IPO secondary market has both by design.
If you've never bought private shares before, you're not on any company's cap table, you have no direct relationship with the company, and you have no independent way to confirm what an operator holds. So when a marquee name appears — a hot AI company, a household growth-stage brand — the only path in is a structure someone else assembled. That is the same access dynamic that makes layered SPVs the default first exposure for most buyers, and it's the same dynamic bad actors rely on.
Three features compound the risk. First, marquee names create demand that outruns scrutiny — the pull of the logo does the selling. Second, closing windows are short: "allocation closes Friday," "soft-circle in 24 hours." Third, pricing is often presented as a discount to the last round without reference to share class, which obscures what the shares are actually worth. A "20% discount to the last round" means little if the shares are common stock sitting behind a large preferred stack — the implied value of common can be a fraction of the headline. (For the underlying math, see Liquidation Preferences Explained and The Last-Round Valuation Myth.)
This market is also unusually concentrated: roughly 86% of 2025 direct secondary volume sat in about 20 companies, which is exactly why demand for access to those specific names is so intense — and why offers claiming to provide it warrant more scrutiny, not less. We cover that dynamic in the market's concentration problem.
When the Companies Themselves Say the Deal Is Void
The clearest signal that unauthorized structures are a live problem is that the underlying companies have started disavowing them directly. In May 2026, both Anthropic and OpenAI warned that transfers of their stock made without board approval are void under their transfer restrictions, and that third parties offering exposure through SPVs, tokenized securities, or forward contracts may not convey any real ownership.
Anthropic's statement was unusually blunt: "We do not permit special purpose vehicles to acquire Anthropic stock and any transfer of shares to an SPV are void under our transfer restrictions," per the company's investor guidance as reported by Decrypt. OpenAI issued a similar warning that unauthorized transactions may violate securities laws and could invalidate the underlying equity. A buyer of such a structure would not be recognized as a shareholder — even after paying full price.
The warnings followed a sharp repricing in tokenized products claiming indirect exposure to the two companies. Tokens issued on Solana fell roughly 40% after the companies flagged that the structures behind them violated their transfer rules, per CoinDesk; one issuer, PreStocks, reportedly showed implied valuations as high as $1.5 trillion for Anthropic while holding only about $23 million in assets. The gap between the exposure being marketed and the assets actually backing it is the whole story in miniature.
For more on this topic
For a deeper walkthrough of how SPV structures work and where their risks concentrate, see Layered SPVs in Venture Secondaries: What Most Investors Are Missing.
What This Means If You're Buying Private Shares
The practical lesson isn't to stay away from venture secondaries. Most transactions in private company shares are legitimate, and a genuine offer holds up to scrutiny. The lesson is that the pitch — the name, the discount, the deadline — tells you almost nothing about whether the deal is real. What tells you is verification.
The three fraud patterns each have a corresponding check. Phantom shares are defeated by confirming the shares exist and the transfer is company-approved. Hidden markups are defeated by learning the operator's cost basis and every fee at every layer. Unauthorized transfers are defeated by confirming the structure complies with the company's transfer restrictions — and, where the company has published guidance (as Anthropic and OpenAI now have), checking that the structure isn't one the company has explicitly disavowed.
One more principle sits above the checklist: legitimate sellers can withstand a thorough buyer. A manufactured urgency that collapses the moment you ask for documentation is itself the answer. If a closing window can't accommodate the diligence the structure requires, that's information — not an inconvenience.
Questions to Get Answered Before You Buy
Before committing capital to any pre-IPO offer, the answers to these should be in writing — not in a verbal pitch:
1. Do the shares actually exist, and is the transfer approved? Has the operator closed the underlying purchase, and has the company's board approved the transfer — or is this contingent on an approval that may never come?
2. What share class is this, and at what price relative to the last priced round? Common or a specific preferred series, and at what implied premium or discount to the most recent priced round of that same class?
3. What did you pay for these shares? What is the operator's cost basis, and what is the spread between that and the price you're being charged?
4. What are all the fees, at every layer? Management fees, carry, transaction and syndication fees — stacked and shown as numbers, not described in general terms.
5. Is the operator registered where required? Is the person selling this a registered broker-dealer or investment adviser where the law requires one — and can they show it?
6. Has the company published anything about unauthorized transfers? Some issuers now state plainly that unapproved transfers, SPVs, or tokenized products are void. Has this structure been disavowed?
An operator who can't or won't answer these in writing is selling access, not ownership. For how private shares are actually valued once you know your share class, see our guide on how private company shares are priced.
A Final Word
An enforcement wave reads like bad news for the pre-IPO market. It's better understood as the market maturing: regulators, and now the companies themselves, are drawing brighter lines around what a valid transfer looks like. That's good for legitimate buyers, because it makes the illegitimate offers easier to spot.
The discipline is the same whether you're buying a single allocation or evaluating a fund: verify what you own before you own it. Access is easy to sell. Ownership is what you're actually paying for — and it's the part worth confirming.
Have questions about a pre-IPO offer?
We're happy to share our perspective.
If you're evaluating a pre-IPO allocation, an SPV, or a "pre-IPO access" product and want a second pair of eyes before you transact, we'd encourage you to reach out. No commitment required.
Get in touch →contact@earlyasset.com · We typically respond within one business day
Earlyasset, Inc. does not provide investment advice and is not a registered investment adviser. Pricing estimates are algorithmic and do not constitute an offer to buy or sell securities. All transactions respect the company's right of first refusal (ROFR) and any transfer restrictions in your equity agreements. Direct liquidity is provided by Earlyasset Capital, LLC, a separate entity from Earlyasset, Inc.
Source note: Information about the SEC's enforcement action against Adit Ventures Management and its principals is based on the Commission's public press release (No. 2026-73) dated August 10, 2026, and contemporaneous reporting by Bloomberg and Reuters; the charges were settled and remain subject to court approval of the consent order, and the firm's CEO has publicly rejected the allegations. Information about the Keyport Venture Advisors and Late Stage Asset Management matters is based on public reporting as of August 2026. Information about Anthropic's and OpenAI's investor guidance on unauthorized transfers is based on public reporting from May 2026. Earlyasset is not affiliated with, and has no non-public information about, any of the companies or parties named. These cases are referenced as documented illustrations of risks in the pre-IPO secondary market; nothing here is a representation about any specific operator active today. Anyone considering a private market transaction should consult their own legal, tax, and financial advisors.